Brian Armstrong on Bitcoin, Anthropic Drops Fable 5 & Mythos 5, NewLimit's $435M Age-Reversal | 264
Brian Armstrong (Coinbase CEO, NewLimit co-founder) joins Peter Diamandis, Alex, Salem, and Dave to discuss Bitcoin's institutional flip, AI agent economies, quantum risk, US government stakes in AI, SpaceX's Dyson swarm ambitions, and NewLimit's $435M age-reversal progress. Packed with specific data, mechanisms, and actionable insights on crypto, AI, and longevity.
Peter Diamandis - host, founder of XPRIZEBrian Armstrong - CEO of Coinbase, co-founder of NewLimitAlex - AI researcher, 'triple major genius'Salem - professor of exo, crypto expertDave Blendon - AI investing wizard
Bitcoin is digital gold but still 70% treated as risk asset; institutional flip is real but slow.
AI agents have already done ~100M transactions on Coinbase; agentic economy needs crypto rails.
Quantum risk to Bitcoin is not imminent but BIP 360 proposes freezing unupgraded coins; Satoshi's 5-10% stash is at risk.
US government exploring 10% stakes in Frontier AI labs; precedent exists in 20+ companies like Intel and Lithium Americas.
OpenAI's S-1 IPO likely at $1.5T+; CFO concerns about compute contracts resolved via leasing Stargate.
SpaceX AI1 satellite (150 kW, 2 tons) is first Dyson swarm node; vertical integration at Gigasat factory enables lunar manufacturing.
NewLimit raised $435M for epigenetic reprogramming; first drug candidates enter clinic in 2025, aiming to reverse cell age without changing cell type.
Columbia University edited PCSK9 and HBG genes in embryos; embryo editing for disease prevention has 80% US support, but enhancement line is blurry.
Bitcoin: Institutional Flip, Price Outlook, and Quantum Risk
City Bank projects Bitcoin at $189,000 by end of 2026; Brian Armstrong sees $100-200k plausible by year-end.
Bitcoin down due to AI absorbing risk capital, stablecoin hype (Genius Act), and inflation trade losing steam.
Bitcoin is digital gold but only ~30% of capital treats it as such; 70% still risk-asset like tech stocks.
Quantum risk: BIP 360 proposes post-quantum cryptography; block size increase contentious; Satoshi's 5-10% coins may be frozen if not upgraded.
Coinbase established Quantum Advisory Council with Dan Boneh, Scott Aaronson, Justin Drake, Yehuda Lindell.
Three options for unupgraded coins: freeze (option A), allow seizure as bounty (B), or hybrid with appeal mechanism.
Bitcoin mining competes with AI for energy and chips; Ethereum moved to proof-of-stake, 99.9% more efficient.
Poly market predicts Bitcoin at $84,000 by end of 2026; daily trading volume 5% vs gold's 0.5%.
AI Agent Economy: Coinbase as Financial Rails for Agents
AI agents have done ~100M transactions and ~$50M value on Coinbase; growing fast.
Three layers: (1) LLMs connected to Coinbase via MCP API, (2) Coinbase Advisor inside app for rebalancing/tax harvesting, (3) self-custodial wallets for agents with no KYC.
Agents can't get credit cards but can use crypto wallets; stablecoins (USDC) enable <1 sec, <1 cent global transfers.
Polytheist view: many specialized AI agents will communicate and transact; agentic economy will exceed human economy.
Liability: agents roll up to human/company; future may see truly autonomous agents with own legal personhood.
On-chain reputation systems (like PageRank) can reduce fraud; FICO-like scores for agents.
Embryo Gene Editing: Columbia University Edits PCSK9 and HBG
Columbia researchers edited PCSK9 (LDL cholesterol) and HBG (hemoglobin) in embryos in vitro.
Base editing (David Liu) allows single nucleotide swaps with minimal errors; better than first-gen CRISPR.
80% of Americans support embryo editing for disease prevention; only 20% for enhancement; line is blurry.
Brian: stronger bones from osteoporosis prevention is both disease prevention and enhancement.
Jurisdiction issues: parents could go to Caribbean island, edit embryo, bring baby back to US.
Nucleus (Ken Sedagi) offers embryo selection from 20 zygotes; Gattaca-like but without editing.
Ethics evolve: IVF was once immoral; now enables millions of families.
Anthropic Fable 5 and Mythos 5: New Frontier Models
Fable 5 is same underlying model as Mythos but with added safeguards; Mythos is less inhibited.
Anthropic retakes lead from GPT-5.5 across most benchmarks; price doubled.
Demonstrations: oneshots cyberpunk FPS with soundtrack; plays Pokémon games via pure visual reasoning (long-range reasoning).
Likely used RLVR (reinforcement learning with verifiable rewards) on long-range challenges (games, code, CTF).
Dave: output is so intelligent it takes time to read; commodity intelligence not happening yet.
Safety vs performance split: same model, different guardrails; safety debate in one sentence.
OpenAI IPO and Compute Shortage
OpenAI filed S-1; Poly market 46% >$1.5T, 26% not this year; third IPO after SpaceX and Anthropic.
CFO Sarah Frier was concerned about $600B compute contracts; resolved by leasing Stargate (not owning).
OpenAI pivoted to Codex, shut down Sora and AI for science; revenue mix inverted from consumer to enterprise.
Dave: CFOs need to accept 3-4 month visibility; singularity means no long-term forecasts.
Brian: healthy tension between founder CEO and CFO; OKRs set uncomfortably ambitious goals (70% hit is good).
Compute shortage: Google renting 110,000 GPUs from SpaceX; all compute sold out.
Passos práticos
If you hold Bitcoin, consider upgrading to post-quantum wallets when BIP 360 is implemented; Coinbase will handle automatically.
Businesses should prepare to accept AI agents as customers by integrating crypto wallets (e.g., Coinbase's self-custodial wallets).
Investors: watch for SpaceX, OpenAI, Anthropic IPOs; be cautious of liquidity crunch and retail risk.
For longevity: consider GLP-1s for potential age reversal; monitor NewLimit's clinical trials starting 2025.
If considering embryo editing, stay informed on jurisdictional options and ethical debates; support disease prevention use cases.
Developers: test Fable 5/Mythos 5 for long-range reasoning tasks; use RLVR for complex challenges.
Policymakers: explore sovereign wealth fund with S&P 500 index to avoid politicization; limit government equity stakes to national security cases.
Frases marcantes
"Bitcoin is the new digital gold. I think it's going to be a key part of our economy going forward into the future."
"The agentic economy has arrived. AI agents are starting to become paying customers using crypto wallets."
"At New Limit, we're trying to do half of what Shinya Yamanaka did. We don't want to change the type of the cell, we just want to change the age."
"If you're a couple and you have the option to have a 7-foot tall child by design, you're going to go to that Caribbean island and make your seven-foot tall for economic reasons."
"The line between disease prevention and enhancement is so blurry that people will start with disease prevention and it'll upgrade over time."
"I think Bitcoin will be the new gold standard and payments will happen on chain. That's the financial system AI agents will use."
Mencionados no episódio
City Bank - projects Bitcoin at $189,000 by 2026
BIP 360 - Bitcoin improvement proposal for post-quantum cryptography
Dan Boneh - Stanford cryptography professor, Quantum Advisory Council member
Scott Aaronson - UT Austin professor, Quantum Advisory Council member
Justin Drake - Ethereum Foundation, Quantum Advisory Council member
Yehuda Lindell - cryptography expert at Coinbase
Genius Act - US stablecoin regulation bill
Base protocol - Coinbase's self-custodial wallet for AI agents
MCP API - interface for LLMs to connect to Coinbase
Coinbase Advisor - in-app AI agent for portfolio management
Stargate - OpenAI's data center project, now leasing model
Codex - OpenAI's coding-focused model
Sora - OpenAI's video generation model (shut down)
AI1 satellite - SpaceX's orbital compute node, 150 kW
Gigasat factory - SpaceX's 1,000-acre satellite production facility in Texas
Colossus 1/2 - xAI's data centers
Grok 5 - xAI's frontier model (delayed)
Cursor - AI coding tool acquired by xAI
NewLimit - Brian Armstrong's longevity company, raised $435M
Shinya Yamanaka - Nobel laureate for cellular reprogramming
Life Bioscience - company dosing first patient with OSK treatment
United Therapeutics - CEO Martine Rothblatt, thymus restoration via iPSCs
Nucleus - embryo selection company (Ken Sedagi)
Fable 5 / Mythos 5 - Anthropic's latest models
GPT-5.5 - OpenAI's previous state-of-the-art
RLVR - reinforcement learning with verifiable rewards
PCSK9 - gene for LDL cholesterol, edited by Columbia
HBG - hemoglobin gene, edited by Columbia
David Liu - inventor of base editing
He Jiankui - Chinese scientist who edited CCR5 in embryos (2018)
Pew Research - 80% support embryo editing for disease prevention
Morgan Stanley - projects SpaceX revenue to $3.4T by 2040
Poly market - prediction markets for Bitcoin, OpenAI IPO, etc.
Fountain Life - health optimization company (sponsor)
Blitzy - autonomous software development platform (sponsor)